Steve,

 MTA is the way to go on this.  However, I'd caution against pre-negotiating future license terms as part of this process.  Standard MTA language offers items for internal evaluation only, with no rights granted and return/disposal of all materials when agreement terminates.  You could even try to limit ability to "reverse engineer", keeping exact structure/composition safe.  Why not consider just sending them a set of coded samples (that's what they'd do if asking you to work with them)?

 There is also good UBMTA language, I believe easily accessed thru AUTM website.  However, you probably will want to use more aggressive terms when dealing with for-profits.

 Caution is advised, and a bit of IP legal advice even.

 Regarding costs, I'd go for what the market will bear.  In this case, all actual costs, shipping, IDC, and maybe a bit of a surcharge?

 Glad to go into more detail if desired.

 David

>Date:    Thu, 22 Jan 2004 14:21:24 -0500
>From:    Steven Etheredge <xxxxxx@GWM.SC.EDU>
>Subject: MTA issues
>
>This is a MIME message. If you are reading this text, you may want to
>consider changing to a mail reader or gateway that understands how to
>properly handle MIME multipart messages.
>
>--=__PartBE9FE3A4.0__=
>Content-Type: text/plain; charset=US-ASCII
>Content-Transfer-Encoding: 7bit
>
>Dear Colleagues:
>
>At our institution, we have a situation where several of our faculty
>have created compounds in their research with internal funding.  While
>the compounds failed to be useful for their intended use because of
>toxicity problems, we have been approached by industry about obtaining
>these compounds for screening to determine if they demonstrate activity
>in the industry's area(s) of intended use.  In past times we have
>provided compounds for such screenings under sponsored research
>agreements.
>
>We now believe that such should be handled as MTA's.  Based on that
>fact, we have encountered several questions/issues with which we need to
>deal.  Those issues are:
snip.,....
--
===========================================================
Mr. David R. Fielder                    tel: 415.600.1600
Vice President Research         fax: 415.600.1753
Research Institute                 email: xxxxxx@cooper.cpmc.org
California Pacific Medical Center  website: http://www.cpmc.org
2200 Webster Street,  Suite 514
San Francisco, CA 94115
===========================================================

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================